X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13972) 13972
Newspaper Article (1102) 1102
Book Chapter (170) 170
Newsletter (39) 39
Magazine Article (33) 33
Book / eBook (24) 24
Trade Publication Article (11) 11
Reference (9) 9
Dissertation (7) 7
Conference Proceeding (3) 3
Web Resource (3) 3
Book Review (2) 2
Publication (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9085) 9085
index medicus (8394) 8394
autoimmune diseases (6693) 6693
female (5163) 5163
male (4303) 4303
animals (3684) 3684
immunology (3554) 3554
adult (3001) 3001
middle aged (2839) 2839
mortality (2442) 2442
mice (2047) 2047
disease (2007) 2007
rheumatology (1982) 1982
risk factors (1919) 1919
aged (1893) 1893
lupus (1840) 1840
autoimmunity (1826) 1826
inflammation (1809) 1809
research (1651) 1651
patients (1592) 1592
systemic lupus erythematosus (1508) 1508
health aspects (1435) 1435
autoimmune diseases - immunology (1354) 1354
care and treatment (1346) 1346
analysis (1330) 1330
medicine (1309) 1309
diagnosis (1295) 1295
adolescent (1220) 1220
immune system (1199) 1199
rheumatoid arthritis (1183) 1183
autoantibodies (1150) 1150
medicine & public health (1139) 1139
cytokines (1115) 1115
studies (1094) 1094
systemic-lupus-erythematosus (1087) 1087
research article (1072) 1072
arthritis (1030) 1030
medical research (1002) 1002
experimental autoimmune encephalomyelitis (998) 998
retrospective studies (973) 973
pathogenesis (964) 964
multiple sclerosis (959) 959
treatment outcome (951) 951
rheumatoid-arthritis (949) 949
multidisciplinary sciences (946) 946
prognosis (942) 942
internal medicine (938) 938
child (934) 934
lymphocytes (932) 932
proteins (921) 921
young adult (894) 894
antibodies (882) 882
hematology (867) 867
cancer (861) 861
diabetes (851) 851
epidemiology (836) 836
risk (834) 834
transplantation (823) 823
prevalence (820) 820
review (814) 814
infections (796) 796
disease models, animal (794) 794
immunoglobulins (793) 793
gastroenterology & hepatology (776) 776
development and progression (772) 772
therapy (772) 772
science (767) 767
neurosciences (758) 758
t cells (750) 750
antigens (741) 741
immunosuppressive agents - therapeutic use (734) 734
autoimmune-diseases (724) 724
autoimmune (720) 720
abridged index medicus (713) 713
hospitals (707) 707
multiple-sclerosis (672) 672
oncology (664) 664
medicine, general & internal (663) 663
expression (661) 661
aged, 80 and over (658) 658
immunotherapy (644) 644
mice, inbred c57bl (640) 640
medicine, research & experimental (639) 639
pregnancy (636) 636
autoimmune disease (624) 624
t-cells (624) 624
cell biology (611) 611
children (607) 607
lymphocytes t (602) 602
gene expression (596) 596
autoimmune diseases - therapy (594) 594
medicine, experimental (594) 594
physiological aspects (588) 588
genetic aspects (585) 585
apoptosis (580) 580
autoimmune-disease (573) 573
dendritic cells (570) 570
rodents (570) 570
age (567) 567
autoimmune diseases - drug therapy (563) 563
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15109) 15109
German (110) 110
Spanish (48) 48
French (44) 44
Japanese (18) 18
Russian (17) 17
Chinese (12) 12
Portuguese (10) 10
Polish (9) 9
Italian (7) 7
Korean (6) 6
Hungarian (4) 4
Croatian (3) 3
Czech (3) 3
Turkish (3) 3
Dutch (2) 2
Norwegian (2) 2
Serbian (2) 2
Slovenian (2) 2
Arabic (1) 1
Bulgarian (1) 1
Finnish (1) 1
Hebrew (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PLoS ONE, ISSN 1932-6203, 04/2017, Volume 12, Issue 4, p. e0175794
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2016, Volume 11, Issue 4, p. e0154441
.... In the past, owing to the low incidence of IIM, little was known about such patients. Our aim was to investigate the clinical features and outcomes of these patients and identify their risk factors for mortality... 
INTERSTITIAL LUNG-DISEASE | AMYOPATHIC DERMATOMYOSITIS | INFECTIONS | PROGNOSTIC-FACTORS | AUTOIMMUNE-DISEASES | MULTIDISCIPLINARY SCIENCES | LONG-TERM OUTCOMES | LUPUS-ERYTHEMATOSUS | PERIPHERAL-BLOOD | SYSTEMIC RHEUMATIC-DISEASES | CRITICALLY-ILL PATIENTS | Prognosis | Lung Diseases, Interstitial - pathology | Humans | Middle Aged | Myositis - mortality | Respiratory Insufficiency - diagnosis | Male | Myositis - complications | Dermatomyositis - mortality | Dermatomyositis - complications | Lung Diseases, Interstitial - mortality | Lung Diseases, Interstitial - diagnosis | China | Pneumonia, Bacterial - mortality | Adult | Female | Myositis - pathology | Retrospective Studies | Pneumonia, Bacterial - pathology | Dermatomyositis - pathology | Respiratory Insufficiency - complications | Intensive Care Units | Tertiary Care Centers | Hospital Mortality | Respiratory Insufficiency - mortality | Pneumonia, Bacterial - complications | Risk Factors | Dermatomyositis - diagnosis | Logistic Models | Myositis - diagnosis | Pneumonia, Bacterial - diagnosis | Lung Diseases, Interstitial - complications | Respiratory Insufficiency - pathology | Survival Analysis | Lymphocyte Count | Aged | APACHE | Infection | Intensive care units | Lung diseases, Interstitial | Care and treatment | Muscle diseases | Management | Risk factors | Pneumonia | Intensive care | Laboratories | Identification methods | Opportunist infection | Infections | Coexistence | Demographics | Diagnosis | Heart failure | Lupus | Mortality | Lung diseases | Rheumatic diseases | Rheumatology | Dermatomyositis | Inflammation | Regression analysis | Risk analysis | Patients | Studies | Polymyositis | Hospitals | Cell number | Medical prognosis
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2015, Volume 74, Issue 6, pp. 1011 - 1018
Objectives To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid syndrome (APS... 
Immunology | Rheumatology | Medicine(all) | Multicenter Study | Biochemistry, Genetics and Molecular Biology(all) | Immunology and Allergy | Journal Article | Observational Study | Systemic Lupus Erythematosus | Antiphospholipid Syndrome | SYSTEMIC-LUPUS-ERYTHEMATOSUS | MANAGEMENT | SERIES | FOLLOW-UP | Anticardiolipin Antibodies | ARTERIAL THROMBOSIS | RHEUMATOLOGY | INTERNATIONAL CONSENSUS STATEMENT | Autoimmune Diseases | COHORT | DISEASE EXPRESSION | CLASSIFICATION CRITERIA | Antiphospholipid Antibodies | MANIFESTATIONS | Antiphospholipid Syndrome - mortality | Lupus Erythematosus, Systemic - complications | Prospective Studies | Humans | Middle Aged | Child, Preschool | Infant | Male | Lupus Erythematosus, Systemic - mortality | Antiphospholipid Syndrome - complications | Epilepsy - etiology | Infection - etiology | Pregnancy Outcome - epidemiology | Young Adult | Abortion, Spontaneous - epidemiology | Antiphospholipid Syndrome - epidemiology | Ischemic Attack, Transient - etiology | Livedo Reticularis - etiology | Aged, 80 and over | Adult | Female | Stroke - mortality | Child | Infant, Newborn | Thrombocytopenia - etiology | Fetal Growth Retardation - epidemiology | Venous Thrombosis - mortality | Infection - mortality | Premature Birth - epidemiology | Venous Thrombosis - etiology | Pregnancy | Pulmonary Embolism - mortality | Stroke - etiology | Pulmonary Embolism - etiology | Thrombosis - etiology | Adolescent | Aged | Thrombosis - mortality | Longitudinal Studies | Cohort Studies | Care and treatment | Patient outcomes | Analysis | Mortality | Risk factors | Morbidity | Antiphospholipid syndrome | Lupus | Anticoagulants | Heart attacks | Morbiditat | Case studies | Síndrome antifosfolipídica | Lupus eritematós | Malalties autoimmunitàries | Estudi de casos | Lupus erythematosus | Autoimmune diseases | Life Sciences | Human health and pathology | Rhumatology and musculoskeletal system
Journal Article
by Weismüller, Tobias J and Trivedi, Palak J and Bergquist, Annika and Imam, Mohamad and Lenzen, Henrike and Ponsioen, Cyriel Y and Holm, Kristian and Gotthardt, Daniel and Färkkilä, Martti A and Marschall, Hanns-Ulrich and Thorburn, Douglas and Weersma, Rinse K and Fevery, Johan and Mueller, Tobias and Chaouillères, Olivier and Schulze, Kornelius and Lazaridis, Konstantinos N and Almer, Sven and Pereira, Stephen P and Levy, Cynthia and Mason, Andrew and Naess, Sigrid and Bowlus, Christopher L and Floreani, Annarosa and Halilbasic, Emina and Yimam, Kidist K and Milkiewicz, Piotr and Beuers, Ulrich and Huynh, Dep K and Pares, Albert and Manser, Christine N and Dalekos, George N and Eksteen, Bertus and Invernizzi, Pietro and Berg, Christoph P and Kirchner, Gabi I and Sarrazin, Christoph and Zimmer, Vincent and Fabris, Luca and Braun, Felix and Marzioni, Marco and Juran, Brian D and Said, Karouk and Rupp, Christian and Jokelainen, Kalle and Benito de Valle, Maria and Saffioti, Francesca and Cheung, Angela and Trauner, Michael and Schramm, Christoph and Chapman, Roger W and Karlsen, Tom H and Schrumpf, Erik and Strassburg, Christian P and Manns, Michael P and Lindor, Keith D and Hirschfield, Gideon M and Hansen, Bettina E and Boberg, Kirsten M and International PSC Study Group and Int PSC Study Grp and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 8, pp. 1975 - 1984.e8
Background & Aims Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary disorder associated with inflammatory bowel disease (IBD... 
Gastroenterology and Hepatology | Risk Stratification | Immune-Mediated Liver Disease | Autoimmune Liver Disease | Cholestasis | DOSE URSODEOXYCHOLIC ACID | RISK-FACTORS | LIVER-TRANSPLANTATION | ALKALINE-PHOSPHATASE | ULCERATIVE-COLITIS | NATURAL-HISTORY | CLINICAL PRESENTATION | PRIMARY BILIARY-CIRRHOSIS | PROGNOSTIC VARIABLES | GASTROENTEROLOGY & HEPATOLOGY | GENOME-WIDE ASSOCIATION | Crohn Disease - epidemiology | Multivariate Analysis | Liver Transplantation | Age Distribution | Prognosis | Humans | Middle Aged | Crohn Disease - surgery | Crohn Disease - mortality | Male | Colitis, Ulcerative - epidemiology | Incidence | Young Adult | Time Factors | Crohn Disease - diagnosis | Adult | Colitis, Ulcerative - surgery | Female | Retrospective Studies | Cholangitis, Sclerosing - surgery | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Europe - epidemiology | Chi-Square Distribution | Australia - epidemiology | Disease Progression | Phenotype | Cholangitis, Sclerosing - epidemiology | Colitis, Ulcerative - diagnosis | Colitis, Ulcerative - mortality | Sex Distribution | Cholangitis, Sclerosing - diagnosis | North America - epidemiology | Cholangitis, Sclerosing - mortality | Gastrointestinal diseases | Genetic aspects | Analysis | Colitis ulcerosa | Inflammation | Inflamació | Ulcerative colitis | Gastroenterologi | risk-factors | association | natural-history | single-center | Gastroenterology & Hepatology | primary biliary-cirrhosis | crohns-disease | genome-wide | clinical presentation | population-based cohort | dose ursodeoxycholic acid | ulcerative-colitis
Journal Article